Disease Control Outcomes from Analysis of Pooled Individual Patient Data from Five Comparative Randomised Clinical Trials of Degarelix Versus Luteinising Hormone-releasing Hormone Agonists
- 1 December 2014
- journal article
- research article
- Published by Elsevier in European Urology
- Vol. 66 (6) , 1101-1108
- https://doi.org/10.1016/j.eururo.2013.12.063
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Neoadjuvant Androgen Deprivation Therapy for Prostate Volume Reduction, Lower Urinary Tract Symptom Relief and Quality of Life Improvement in Men with Intermediate- to High-risk Prostate Cancer: A Randomised Non-inferiority Trial of Degarelix versus Goserelin plus BicalutamideClinical Oncology, 2013
- A Phase III Extension Trial With a 1-Arm Crossover From Leuprolide to Degarelix: Comparison of Gonadotropin-Releasing Hormone Agonist and Antagonist Effect on Prostate CancerJournal of Urology, 2011
- Are gonadotrophins tumorigenic—A critical review of clinical and experimental dataMolecular and Cellular Endocrinology, 2010
- Prostate-Specific Antigen Progression Predicts Overall Survival in Patients With Metastatic Prostate Cancer: Data from Southwest Oncology Group Trials 9346 (Intergroup Study 0162) and 9916Journal of Clinical Oncology, 2009
- Effects of Gonadotrophin‐Releasing Hormone Outside the Hypothalamic‐Pituitary‐Reproductive AxisJournal of Neuroendocrinology, 2009
- The efficacy and safety of degarelix: a 12‐month, comparative, randomized, open‐label, parallel‐group phase III study in patients with prostate cancerBJU International, 2008
- Absolute Prostate-Specific Antigen Value After Androgen Deprivation Is a Strong Independent Predictor of Survival in New Metastatic Prostate Cancer: Data From Southwest Oncology Group Trial 9346 (INT-0162)Journal of Clinical Oncology, 2006
- Comparison of 10 serum bone turnover markers in prostate carcinoma patients with bone metastatic spread: Diagnostic and prognostic implicationsInternational Journal of Cancer, 2004
- Skeletal Fractures Negatively Correlate With Overall Survival in Men With Prostate CancerJournal of Urology, 2002
- HIGH INCIDENCE OF RECEPTORS FOR LUTEINIZING HORMONE-RELEASING HORMONE (LHRH) AND LHRH RECEPTOR GENE EXPRESSION IN HUMAN PROSTATE CANCERSJournal of Urology, 2000